Loading...

LTRN LANTERN PHARMA INC Management Changes 8-K Filing

LNTR

LTRN

LANTERN PHARMA INC

(LTRN)

2025 8-K

AI Platform Demonstration

Financial Results Release

AI Tools Presentation

Financial Results Announcement

Annual Meeting Results

Financial Results Announcement

Equity Offerings

Financial Statements

Financial Results

Management Changes

Q3 Results Call

Q3 Earnings Announcement

Annual Meeting of Stockholders

By-laws Amendment

Earnings Reports

Earnings Reports

Management Changes

Investment Agreement

Death of Director

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Salary Increase

External Links:

On July 24, 2025, Lantern Pharma Inc. appointed Dr. Lee T. Schalop to its Board of Directors and amended its By-laws to reduce the quorum requirement for stockholder meetings from a majority to one-third of shares entitled to vote.

AI Assistant

LANTERN PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.